Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired

Clinical and Experimental Immunology

Volumn 108, Issue 1, 1997, Pages 1-8

  Thon, V ^a,b   Eggenbauer, H ^a   Wolf, H M ^a   Fischer, M B ^a   Litzman, J ^b   Lokaj, J ^b   Eibl, M M ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b MASARYK UNIVERSITY   (Czech Republic)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antigen presentation; B cells; Common variable immunodeficiency; Monocytes

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030942050     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-989.x     Document Type: Article

References (37)

1. Germain RH, Marguiles DM. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993; 11:403-50.
2. Knight SC, Stagg AJ. Antigen-presenting cell types. Curr Opin Immunol 1993; 5:374-82.
3. Germain RH. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76:287-99.
4. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76:275-85.
5. Geha RS, Rosen FS. The genetic basis of immunoglobulin-class switching [editorial]. N Engl J Med 1994; 330:1008-9.
6. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 1992; 13:431-3.
7. Stagg AJ, Funauchi M, Knight SC, Webster AD, Farrant J. Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1994; 96:48-53.
8. Fischer MB, Hauber I, Eggenbauer H et al. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood 1994; 84:4234-41.
9. Fischer MB, Wolf HM, Hauber I, Eggenbauer H, Thon V, Sasgary M, Eibl MM. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol 1996; 26:231-7.
10. Todd JA, Bell JI, McDevitt. HLA-DQ-beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329:599-604.
11. Castano L, Eisenbarth GS. Type I diabetes: chronic autoimmune disease of human and rat. Annu Rev Immunol 1990; 8:647-79.
12. Cohen-Hauguenauer O, Robbins E, Massart C et al. A systemic study of HLA class II-b DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1985; 82:3335-9.
13. Hattori M, Buse JB, Jackson RA et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 1986; 231:733-5.
14. Todd JA, Aitman TJ, Cornall RJ et al. Genetic analysis of autoimmune type I diabetes mellitus in mice. Nature 1991; 351:542-7.
15. g7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 1996; 156:450-8.
16. Ellerman KE, Like AA. A major histocompatibility complex class II restriction for BioBreeding/Worcester diabetes-inducing T cells. J Exp Med 1995; 182:923-30.
17. Olerup O, Smith CIE, Björkander J, Hammarström L. Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci USA 1992; 89:10653-7.
18. Ashman RF, Schaffer FM, Kemp JD, Yokoyama WM, Zhu Z-B, Cooper MD, Volanakis JE. Genetic and immunologic analysis of a family containing five patients with common-variable immune deficency or selective IgA deficiency. J Clin Immunol 1992; 12:406-14.
19. Schaffer FM, Palermos J, Zhu Z-B, Barger BO, Cooper MD, Volanakis JE. Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci USA 1989; 86:8015-9.
20. Volanakis JE, Zhu ZB, Schaffer FM et al. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Invest 1992; 89:1914-22.
21. Howe HS, So AKL, Farrant J, Webster ADB. Common variable immunodeficiency is associated with polymorphic markers in the human major histocompatibility complex. Clin Exp Immunol 1991; 84:387-90.
22. Vorechovsky I, Zetterquist H, Paganelli R, Koskinen S, Webster ADB, Björkander J, Smith CIE, Hammarström L. Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995; 77:185-2.
23. Powis SH, Cooper MD, Trowsdale J, Zhu Z-B, Volanakis JE. Major histocompatibility haplotypes associated with immunoglobulin-A deficiency and common variable immunodeficiency: analysis of the peptide transporter genes TAP1 and TAP2. Tissue Antigens 1994; 43:261-5.
24. Eibl MM, Mannhalter JW, Zlabinger G, Mayr WR, Tilz GP, Ahmad R, Zielinski CC. Defective macrophage function in a patient with common variable immunodeficiency. N Engl J Med 1982; 307:803-6.
25. Fischer MB, Hauber I, Wolf HM, Vogel E, Mannhalter JW, Eibl MM. Impaired TCR signal transduction, but normal antigen presentation, in a patient with common variable immunodeficiency. Br J Haematol 1994; 88:520-6.
26. Rosen FS, Wedgwood JP, Eibl M et al. Primary Immunodeficiency Diseases. Report of a WHO Scientific Group. Clin Exp Immunol 1995; 99(Suppl. 1):1-24.
27. Hauber I, Guile H, Wolf HM, Maris M, Eggenbauer H, Eibl MM. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients. J Exp Med 1995; 181:1411-23.
28. Aman P, Ehlin-Henriksson B, Klein G. Epstein-Barr virus susceptibility of normal human B lymphocyte populations. J Exp Med 1984; 159:208-20.
29. North ME, Spickett GP, Allsop J, Webster ADB, Farrant J. Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens. Clin Exp Immunol 1989; 76:19-23.
30. Pastorelli G, Roncarolo MG, Touraine JL, Perone G, Tovo PA, de Vries JE. Peripheral blood lymphocytes of patients with common variable immunodeficiency produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Clin Exp Immunol 1989; 78:334-40.
31. Eibl MM, Mannhalter JW, Zielinski CC, Ahmad R. Defective macrophage-T-cell interaction in common varied immunodeficiency. Clin Immunol Immunopathol 1982; 22:316-22.
32. Stagg AJ, Funauchi M, Knight SC, Webster ADB, Farrant J. Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1994; 96:48-53.
33. + T cells. Clin Exp Immunol 1995; 101:82-88.
34. Truedsson L, Baskin B, Pan Q, Rabbani H, Vorechovsky I, Smith CIE, Hammarström L. Genetics of IgA deficiency. APMIS 1995; 103:833-42.
35. Spickett GP, Webster ADB, Farrant J. Cellular abnormalities in common variable immunodeficiency. Immunodefic Rev 1990; 2:199-219.
36. Saiki O, Ralph P, Cunningham-Rundles C, Good RA. Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci USA 1982; 79:6008-12.
37. Bryant A, Calver NC, Toubi E, Webster ADB, Farrant J. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 1990; 56:239-48.